Eric A Adams insider trades

Open-market stock purchases and sales by Eric A Adams, President & CEO at InMed Pharmaceuticals Inc, from SEC Form 4 filings since Dec 16, 2020.

Track record: 60% of 5 scored buys are up 5% or more since purchase, averaging +69%.

Recent trades

DateStockTradeValue
Dec 19, 2025INM InMed Pharmaceuticals IncBought (not open market)—
Dec 15, 2025INM InMed Pharmaceuticals IncSold (not open market)—

Companies traded

  • INM InMed Pharmaceuticals Inc: 5 buys, last Dec 19, 2025

Get free alerts when Eric A Adams files a new trade →